An Australian study has linked rapidly growing mycobacterium infections to gastric banding surgery, but no clear source has been identified, according to an article published online September 10 in ...

MicuRx Pharmaceuticals, Inc. ("MicuRx"), a clinical-stage biopharmaceutical company focused on developing novel anti-infective therapies for drug-resistant bacterial infections, recently announced ...

Accurate detection is essential to prevent misdiagnosis and ensure the right treatment, particularly in cases involving drug-resistant TB or NTM infections. The Hi-PCR ® MTB/NTM Probe PCR Kit offers a ...

The immune system remains seriously out-of-whack—in an inflammatory state of overactivation and impaired functionality—following the international gold standard for treating people with latent ...

Mycobacterium abscessus is a fast-growing, pathogenic mycobacteria that can cause lung infections, and people who have respiratory conditions or are immunocompromised face a higher risk. It can also ...

Singapore, 6 June 2023 - Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research ...

NEW YORK — Two treatments that don't involve antibiotics have moved from the laboratory into clinical testing for control of nontuberculous mycobacteria (NTM) pulmonary disease, according to separate ...

Mycobacteria are the world's most deadly bacteria --c ausing infectious diseases including tuberculosis (TB), which alone kills more than one million people each year. New drugs to fight these ...

Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden of current therapy.